The FDA has said it will expand unannounced inspections of overseas manufacturing facilities supplying medicine and other medical products to the US. The aim is to make sure that foreign companies ...

China has been a challenging market for AstraZeneca in the last few months but, undeterred, it has just announced a $2.5 billion investment programme in what is the world's second-largest pharma ...